Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression. 2012

Joana Rosmaninho-Salgado, and Ana Patricia Marques, and Marta Estrada, and Magda Santana, and Vera Cortez, and Eric Grouzmann, and Cláudia Cavadas
CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Portugal.

We evaluated the effects of dipeptidyl peptidase-IV (DPPIV), and its inhibitor, vildagliptin, on adipogenesis and lipolysis in a pre-adipocyte murine cell line (3T3-L1). The exogenous rDPPIV increased lipid accumulation and PPAR-γ expression, whereas an inhibitor of DPPIV, the anti-diabetic drug vildagliptin, suppresses the stimulatory role of DPPIV on adipogenesis and lipid accumulation, but had no effect on lipolysis. NPY immunoneutralization or NPY Y(2) receptor blockage inhibited DPPIV stimulatory effects on lipid accumulation, collectively, indicating that DPPIV has an adipogenic effect through NPY cleavage and subsequent NPY Y(2) activation. Vildagliptin inhibits PPAR-γ expression and lipid accumulation without changing lipolysis, suggesting that this does not impair the ability of adipose tissue to store triglycerides inside lipid droplets. These data indicate that DPPIV and NPY interact on lipid metabolism to promote adipose tissue depot.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D009478 Neuropeptide Y A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones. Neuropeptide Y-Like Immunoreactive Peptide,Neuropeptide Tyrosine,Neuropeptide Y Like Immunoreactive Peptide,Tyrosine, Neuropeptide
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D000077597 Vildagliptin A pyrrolidine-carbonitrile derivative and potent inhibitor of DIPEPTIDYL PEPTIDASE 4 that is used in the treatment of TYPE 2 DIABETES MELLITUS. (2S)-(((3-Hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile,Galvus,NVP-LAF237,NVP LAF237
D000218 Adamantane A tricyclo bridged hydrocarbon. Diamantane
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D017476 Receptors, Neuropeptide Y Cell surface proteins that bind neuropeptide Y with high affinity and trigger intracellular changes which influence the behavior of cells. Neuropeptide Y Receptors,Neuropeptide Y Receptor,Receptor, Neuropeptide Y

Related Publications

Joana Rosmaninho-Salgado, and Ana Patricia Marques, and Marta Estrada, and Magda Santana, and Vera Cortez, and Eric Grouzmann, and Cláudia Cavadas
December 1993, Regulatory peptides,
Joana Rosmaninho-Salgado, and Ana Patricia Marques, and Marta Estrada, and Magda Santana, and Vera Cortez, and Eric Grouzmann, and Cláudia Cavadas
February 2007, Peptides,
Joana Rosmaninho-Salgado, and Ana Patricia Marques, and Marta Estrada, and Magda Santana, and Vera Cortez, and Eric Grouzmann, and Cláudia Cavadas
January 2006, Advances in experimental medicine and biology,
Joana Rosmaninho-Salgado, and Ana Patricia Marques, and Marta Estrada, and Magda Santana, and Vera Cortez, and Eric Grouzmann, and Cláudia Cavadas
January 2006, Advances in experimental medicine and biology,
Joana Rosmaninho-Salgado, and Ana Patricia Marques, and Marta Estrada, and Magda Santana, and Vera Cortez, and Eric Grouzmann, and Cláudia Cavadas
March 2019, Medicine,
Joana Rosmaninho-Salgado, and Ana Patricia Marques, and Marta Estrada, and Magda Santana, and Vera Cortez, and Eric Grouzmann, and Cláudia Cavadas
July 2003, Pharmacology, biochemistry, and behavior,
Joana Rosmaninho-Salgado, and Ana Patricia Marques, and Marta Estrada, and Magda Santana, and Vera Cortez, and Eric Grouzmann, and Cláudia Cavadas
November 2013, Rheumatology international,
Joana Rosmaninho-Salgado, and Ana Patricia Marques, and Marta Estrada, and Magda Santana, and Vera Cortez, and Eric Grouzmann, and Cláudia Cavadas
January 2021, Biomedical research (Tokyo, Japan),
Joana Rosmaninho-Salgado, and Ana Patricia Marques, and Marta Estrada, and Magda Santana, and Vera Cortez, and Eric Grouzmann, and Cláudia Cavadas
March 2001, Peptides,
Joana Rosmaninho-Salgado, and Ana Patricia Marques, and Marta Estrada, and Magda Santana, and Vera Cortez, and Eric Grouzmann, and Cláudia Cavadas
May 2018, Life sciences,
Copied contents to your clipboard!